Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines

International Journal of Cancer

Volumn 68, Issue 2, 1996, Pages 259-264

  Wasilenko, William J ^a,b   Palad, Ann J ^a,b   Somers, Kenneth D ^a,b   Blackmore, Peter F ^a,b   Kohn, Elise C ^c   Rhim, Johng S ^d   Wright Jr , George L ^a,b   Schellhammer, Paul F ^a,b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Sentara Cancer Resource Centers   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN; CALCIUM CHANNEL BLOCKING AGENT; CARBACHOL; CARBOXYAMIDO TRIAZOLE; MATRIGEL; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM TRANSPORT; CELL INVASION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CALCIUM; CELL DIVISION; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TRIAZOLES; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0029819854     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961009)68:2<259::AID-IJC20>3.0.CO;2-4     Document Type: Article

References (23)

1. BLACKMORE, P.F., OAKES, S.G. and SOMERS, K.D., Altered H1 histamine receptor signaling in BALB/3T3 cells transformed by v-K-ras and v-H-ras oncogenes. Oncogene, 7, 2053-2057 (1992).
2. CHEN, T.R., Chromosome identity of human prostate cancer cell lines PC-3 and PPC-1. Cytogenet. Cell Genet., 62, 183-184 (1993).
3. CHUNG, L.W.K., Fibroblasts are critical determinants in prostatic cancer growth and dissemination. Cancer Metastasis Rev., 10, 263-274 (1991).
4. COLE, K.A. and KOHN, E.G., Calcium-mediated signal transduction: biology, biochemistry, and therapy. Cancer Metastasis Rev., 13, 33-41 (1994).
5. FELDER, C.C., MA, A.L., LIOTTA, L.A. and KOHN, E.C., The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetycholine receptor-stimulated calcium influx and arachidonic acid release. J. Pharmacol. Exp. Ther., 257, 967-971 (1991).
6. HUPE, D.J., BEHRENS, N.D. and BOLTZ, R., Anti-proliferative activity of L-651,582 correlates with calcium-mediated regulation of nucleotide metabolism at phosphoribosyl pyrophosphate synthetase. J. cell Physiol., 144, 457-466 (1990).
7. HUPE, D.J., BOLTZ, R., COHEN, C.J., FELIX, J., HAM, F., MILLER, D., SODERMAN, D. and VAN SKIVER, D., The inhibition of receptor-mediated and voltage dependent calcium entry by the antiproliferative L-651,582. J. biol. Chem., 266, 10136-10142 (1991).
8. ISAACS, J.T., SCHULZE, H. and COFFEY, D.S., Development of androgen resistance in prostatic cancer. In: G.P. Murphy, S. Khoury, I.R. Kuss, C. Chatelain and L. DENIS (EDS.), Prostate cancer, part A: research, endocrine treatment, and histopathology, pp. 21-31, A.R. Liss, New York (1987).
9. KAIGHN, M.E., REDDEL, R.R., LECHNER, T.J., PEEHL, D.M., CAMALIER, R.F., BRAH, D.E., SAFFIOTTI, U. and HARRIS, C.C., Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. Cancer Res., 49, 3050-3056 (1989).
10. KOHN, E.C., ALESSANDRO, R., SPOONSTER, J., WERSTO, R.W. and LIOTTA, L.A., Angiogenesis: role of calcium-mediated signal transduction. Proc. not. Acad. Sci. (Wash.), 92, 1307-1311 (1995).
11. KOHN, E.C., FELDER, C.C., JACOBS, W., HOLMES, K.A., DAY, A., FREER, R. and LIOTTA, L.A., Structure-function analysis of signal and growth inhibition by carboxyamidotriazole, CAI. Cancer Res., 54, 935-942 (1994a).
12. KOHN, E.C., JACOBS, W., KIM, Y.S., ALESSANDRO, R., STETLER- STEVENSON, W.G. and LIOTTA, L.A., Calcium influx regulates matrix metalloproteinase-2 (72 kDa type IV collagenase, gelatinase A) expression. J. biol. Chem., 269, 21505-21511 (19946).
13. KOHN, E.C. and LIOTTA, L.A., Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res., 55, 1856-1862 (1995).
14. KOHN, E.G., REED, E., SAROSY, E., CHRISTIAN, M., LINK, C.J., COLE, K.A., FIGG, W.D., DAVIS, P.A., JACOB, J., GOLDSPIEL, B. and LIOTTA, L.A., Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers. Cancer Res., 56, 569-573 (1996).
15. KOHN, E.G., SANDEEN, M.A. and LIOTTA, L.A., In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res., 52, 3208-3212 (1992).
16. LEE, M.S., GARKOVENKO, E., YUN, J.S., WEIJERMAN, P.C., PEEHL, D.M., CHEN, L.S. and RHIM, J.S., Characterization of adult human prostatic epithelial cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin-defective SV 40 genome. Int. J. Oncol., 4, 821-830 (1994).
17. LEVITZKI, A., Signal-transduction therapy: a novel approach to disease management. Europ. J. Biochem., 226, 1-13 (1994).
18. POWIS, G., Signaling targets for anticancer drug development. Trends Pharmacol. Sci., 12, 188-194 (1991).
19. RHIM, J.S., JAY, G., ARNSTEIN, P., PRICE, P.M., SANFORD, K.K. and AARONSON, S., Neoplastic transformation of human epidermal keratinocytes by Ad12-SV40 and Kirsten sarcoma viruses. Science, 227, 1250-1252 (1985).
20. STAMEY, T.A. and KABALIN, J.N., Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. J. Urol., 141, 1070-1075 (1989).
21. WARE, J.L., Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev., 12, 287-301 (1993).
22. WASILENKO, W.J., COOPER, J., PALAD, A.J., SOMERS, K.D., BLACKMORE, P.P., RHIM, J.S., WRIGHT, G.L. and SCHELLHAMMER, P.P., Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP. Prostate (In press) (1996).
23. YEH, Y.A., HERENYIOVA, M. and WEBER, G., Quercetin: synergistic action with carboxyamidotriazole in human breast carcinoma cells. Life Sci., 57, 1285-1292 (1995).